Bempikibart (ADX-914) is under development for the treatment of atopic dermatitis and alopecia areata. It is administered through subcutaneous route and acts by targeting interleukin-7 receptor (IL-7R ...

Amgen has a strong product portfolio, pipeline developments, and robust financial health. Read why AMGN stock is a Strong Buy ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...

Medically reviewed by Jurairat J. Molina, MD Dermatitis is a group of skin problems related to genes, environment, and ...

New data reveals that longer-term lebrikizumab treatment significantly improves outcomes for patients with moderate-to-severe atopic dermatitis who didn’t meet response criteria by week 16.

A daily cream containing a GluK2-activating compound could therefore be a promising way to prevent several inflammatory skin conditions.

ATOPIC dermatitis (AD), a chronic inflammatory skin condition, affects millions globally and is linked to systemic immune ...

The following is a summary of “Fungal Head and Neck Dermatitis: Current Understanding and Management,” published in the July ...

Inflammation is a crucial part of the body's defense mechanism, playing a key role in fighting infections and repairing ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Eczema symptoms can be mild — a small patch of itchy, dry, red or pink textured skin — or they can be severe, Dr. Shasa Hu, associate professor in the department of dermatology and cutaneous surgery ...